deltatrials
Terminated PHASE3 NCT00208221

Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

Comparison of a Higher Dose of Ramipril to the Addition of Telmisartan 80 mg+Ramipril 10 mg in Patients With Hypertension and Diabetes

Sponsor: Institut de Recherches Cliniques de Montreal

Conditions Albuminuria Hypertension Type 2 Diabetes
Interventions ramipril ramipril-telmisartan
Updated 5 times since 2017 Last updated: Nov 7, 2007 Started: Aug 31, 2006 Completion: Jun 30, 2007

This PHASE3 trial investigates Albuminuria and Hypertension and is currently terminated or withdrawn. Institut de Recherches Cliniques de Montreal leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut de Recherches Cliniques de Montreal
Data source: Institut de Recherches Cliniques de Montreal

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Montreal, Canada